Showing 1041-1050 of 2105 results for "".
Pseudotumor Cerebri Syndrome Related to a Dural Arteriovenous Fistula After Vascular Trauma
https://practicalneurology.com/diseases-diagnoses/headache-pain/pseudotumor-cerebri-syndrome-related-to-a-dural-arteriovenous-fistula-after-vascular-trauma/32091/A case of secondary pseudotumor cerebri caused by dural arteriovenous fistula development after an injury repaired by jugular vein ligation.Revolutions in Spinal Muscular Atrophy Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/revolutions-in-spinal-muscular-atrophy-treatment/31895/Potential Uses of ATX(N) Classification of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/potential-uses-of-atxn-classification-of-alzheimer-disease/31792/The ATX(N) classification system has potential uses in clinical practice and therapy development for Alzheimer disease.Seeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBRising Drug Prices and the Cost of Care: What Can Physicians Do?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/rising-drug-prices-and-the-cost-of-care-what-can-physicians-do/30327/The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.Expert Perspective on Ocrelizumab and More
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/expert-perspective-on-ocrelizumab-and-more/30368/Niche No Longer: Bringing Sleep Medicine to the Forefront of Neurological Practice
https://practicalneurology.com/diseases-diagnoses/sleep/niche-no-longer-bringing-sleep-medicine-to-the-forefront-of-neurological-practice/30415/Emerging insights in the realm of sleep are shaping new understandings of neurological diseases.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.New Option Now Available for DBS for PD, Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/new-option-now-available-for-dbs-for-pd-tremor/30551/As Treatment Options Expand, Researchers Continue to Explore the Basis of MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/as-treatment-options-expand-researchers-continue-to-explore-the-basis-of-ms/30601/New treatments have emerged and others are expected. What have changes meant for patient care?